|
Volumn 33, Issue 4, 2001, Pages 2571-2575
|
Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: A multicenter, open-label study
a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOMEGALOVIRUS ANTIBODY;
GANCICLOVIR;
ADULT;
ARTICLE;
BACKACHE;
BONE PAIN;
CHILL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FLUSHING;
HUMAN;
HYPOTENSION;
LIVER TRANSPLANTATION;
MALE;
MULTICENTER STUDY;
ORGAN DONOR;
PRIORITY JOURNAL;
SEROCONVERSION;
ADULT;
ANTIVIRAL AGENTS;
COMBINED MODALITY THERAPY;
CYCLOSPORINE;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTIONS;
FEMALE;
GANCICLOVIR;
HUMANS;
IMMUNIZATION, PASSIVE;
IMMUNOGLOBULINS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
MUROMONAB-CD3;
PLACEBOS;
TISSUE DONORS;
|
EID: 0034850474
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02101-7 Document Type: Article |
Times cited : (37)
|
References (22)
|